Zai Lab (Shanghai) Co., Ltd.
Clinical trials sponsored by Zai Lab (Shanghai) Co., Ltd., explained in plain language.
A commercial-stage biopharmaceutical company developing and commercializing medicines.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- First human test of ZL-1503 begins to uncover how the body handles it Results expected Feb 2027 (estimated)
- New hope for thyroid eye disease: phase 3 drug trial launches in china Results expected Mar 2027 (estimated)
- New drug cocktail targets tough lung cancer Results expected May 2027 (estimated)
- New drug ZL-1310 tested in patients with Hard-to-Treat cancers Results expected Aug 2027 (estimated)
- Can a new drug ease schizophrenia symptoms in daily life? Results expected Aug 2027 (estimated)